2. Signaling Pathways
  3. Protein Tyrosine Kinase/RTK
  4. FGFR
  5. FGFR Agonist

FGFR Agonist

FGFR Isoform Comparison

FGFR Agonist (1):

Cat. No. Product Name Effect Purity
  • HY-P99614
    Fazpilodemab
    		Agonist ≥99.0%
    Fazpilodemab (BFKB8488A) is a humanized, agonistic, bispecific antibody targeting fibroblast growth factor receptor 1c (FGFR1c) and Klothoβ. Fazpilodemab can be used for the research of type 2 diabetes mellitus (T2DM) or nonalcoholic fatty liver disease (NAFLD).